Vertex Pharmaceuticals Inc. buy Evercore ISI
Start price
11.04.24
/
50%
€370.60
Target price
11.04.25
€407.65
Performance (%)
16.50%
End price
12.04.25
€431.75
Summary
This prediction ended on 12.04.25 with a price of €431.75. The prediction had a final performance of 16.50%. Evercore_ISI has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Evercore_ISI has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 3.930% | 3.930% | -7.796% |
| iShares Core DAX® | -0.383% | 1.093% | 11.642% |
| iShares Nasdaq 100 | -0.411% | -1.973% | 7.273% |
| iShares Nikkei 225® | 1.838% | 10.261% | 31.381% |
| iShares S&P 500 | -0.712% | 0.445% | 4.295% |
Comments by Evercore_ISI for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $438.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Evercore_ISI for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€334.05
11.09.25
11.09.25
€406.03
11.09.26
11.09.26
25.86%
27.02.26
27.02.26
Stopped prediction by Evercore_ISI for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€399.15
23.01.26
23.01.26
€451.19
23.01.27
23.01.27
5.34%
27.02.26
27.02.26